Full Text View
Tabular View
Study Results
Related Studies
Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate
This study has been completed.
Study NCT00939562   Information provided by Pfizer

First Received on July 8, 2009.   Last Updated on November 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacterial Infection
Additional conditions recognized in this trial
Bacterial Infections
Interventions listed in this trial
doxycycline monohydrate tablet
doxycycline carragenate tablet
Additional drug interventions recognized in this trial
Doxycycline
Doxycycline hyclate
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services